![716 Mini-Dose of Glucagon: Great Efficacy Avoiding Admission of Insulin-Dependent-Diabetic Children with Decreasing Normoglycemie or Hypoglycemie Due to Vomiting or Gastroenteritis | Pediatric Research 716 Mini-Dose of Glucagon: Great Efficacy Avoiding Admission of Insulin-Dependent-Diabetic Children with Decreasing Normoglycemie or Hypoglycemie Due to Vomiting or Gastroenteritis | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1203%2F00006450-201011001-00716/MediaObjects/41390_2010_Article_BFpr2010925_Figa1_HTML.jpg)
716 Mini-Dose of Glucagon: Great Efficacy Avoiding Admission of Insulin-Dependent-Diabetic Children with Decreasing Normoglycemie or Hypoglycemie Due to Vomiting or Gastroenteritis | Pediatric Research
![Molecules | Free Full-Text | What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?—A Mini Review Molecules | Free Full-Text | What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?—A Mini Review](https://www.mdpi.com/molecules/molecules-26-04822/article_deploy/html/images/molecules-26-04822-g001.png)
Molecules | Free Full-Text | What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?—A Mini Review
![Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells | Circulation Research Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells | Circulation Research](https://www.ahajournals.org/cms/asset/5108528c-7cdc-4d2f-8788-761b877068b6/hh0160114004.jpeg)
Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells | Circulation Research
![Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Media Centre | EASD Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/806_607206/Slide1.jpg)
Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Media Centre | EASD
![Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients Xeris Doses First Patient in Phase 2 Study of Mini-dose Glucagon for mild-moderate hypoglycemia in T1D patients](https://diatribe.org/cdn-cgi/image/width=400/sites/default/files/images/GPEN%20Mini%20Model%20Xeris.jpg)